Is Sorafenib a chemotherapy drug?

SorafenibIt is not a chemotherapy drug, it is a targeted drug. Sorafenib is a tyrosine kinase inhibitor (TKI) and a VEGF inhibitor. span>Angiogenesis inhibitor), sorafenib is FDA approved for the treatment of liver cancer, thyroid cancer and kidney cancer. Targeted drug therapies find and attack specific types of cancer cells, which may cause less damage to healthy cells, but serious side effects can still occur. Chemotherapy works by killing fast-growing cancer cells, but it can also affect normal cells without allowing cancer cells to grow. Both types of treatment can be associated with serious life-threatening side effects.

Sorafenib was first approved by the FDA in 2005 and is manufactured by Bayer Pharmaceuticals. Sorafenib is supplied as film-coated tablets containing 200 mg of sorafenib(equivalent to 274 mgSorafenib tosylate)and the following inactive ingredients:Crosscarmellose sodium, iron oxide red, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol sodium lauryl sulfate, and titanium dioxide. Steady-state concentrations of sorafenib were evaluated following twice daily administration of sorafenib 400 mg in patients with DTC, RCC, and HCC. The average steady-state concentration of DTC patients was 1.8 times higher than that of HCC patients and 2.3 times higher than that of patients with renal cell carcinoma. DTCThe reason for the patient's elevated sorafenib concentration is unclear. The retail price of Bangladesh Yaopin International Pharmaceutical 0.2g*120 tablets is about 700 yuan. The retail price of pharmaceuticals in Laos and ASEAN is about 0.2g*56 tablets500yuan. IndiaNATCOThe retail price of pharmaceuticals is about 0.2g*120 tablets1000 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.